Helene Servillon @ JourneyOne 🌱

Fund Manager investing in frontier wellness @journeyonevc 506c fund. GP community @allraise @global_transact @recastcapital. @Northeastern volleyball

[Helene Servillon @ JourneyOne 🌱 @HServillon]

Any angel investors in town for SF tech week? I'd love to invite you to an amazing wellness inspired event just for investors. DM me

[Sydecar @sydecario]

Our webinar is just over 24 hours away!

Tomorrow from 2-3p ET, we're hosting an educational session, "Transforming Your Syndicate Management", where top industry leaders will offer their expertise on running syndicates efficiently and steering clear of common challenges.

Our panel includes three syndicate experts:

-Helene Servillon (@HServillon), Founding Partner, JourneyOne Ventures
-Tyler Knight (@TK_H_E_N_R_Y_7), Founder & GP, Vannevar Ventures
-Murat Abdrakhmanov (@muratma7), Founder, MA7 VC Fund

Our panelists will cover:
-Building stronger LP relationships
-Mechanics of co-syndication
-How to price the economics of your syndicate
-Leveraging cutting-edge tools for syndicate success

If you're looking to streamline your syndicate operations and build stronger investor relationships, register here: https://t.co/RHcPRX1AWs

[Helene Servillon @ JourneyOne 🌱 @HServillon]

Whatcha wanna know about running an angel investor syndicate? Drop in with us next Tues! 👇

[Sydecar @sydecario]

Our Sydecar Session webinar is one week away!

Next Tuesday, October 1st, we're hosting an educational session, "Transforming Your Syndicate Management", where industry leaders will share their insights on managing syndicates effectively and avoiding common pitfalls.

Our panel includes three syndicate experts:

-Helene Servillon (@HServillon), Founding Partner, JourneyOne Ventures
-Tyler Knight (@TK_H_E_N_R_Y_7), Founder & GP, Vannevar Ventures
-Murat Abdrakhmanov (@muratma7), Founder, MA7 VC Fund

Topics include:
✅ Key strategies for effective syndicate management
✅ How to strengthen your investor relations
✅ Ways to optimize your deal flow and simplify operations with Sydecar’s new Syndicate platform

If you're looking to streamline your syndicate operations and build stronger investor relationships, register here: https://t.co/RHcPRX1AWs

[Helene Servillon @ JourneyOne 🌱 @HServillon]

For those of you who call cannabis a vice… DEA is re scheduling it to 3 when alcohol and tobacco and not scheduled at all...

What other status quos are limiting us?

This plant is used for…
Epilepsy
Cancer ailments
Anxiety
Sleep

The science will follow very soon!

[President Biden Archived @POTUS46Archive]

Too many lives have been upended because of our failed approach to marijuana.

So today, the @TheJusticeDept is taking the next step to reclassify marijuana from a Schedule I to a Schedule III drug under federal law.

Here's what that means:

[Helene Servillon @ JourneyOne 🌱 @HServillon]

@noahsfriedman @iiiitsandrea @thesnaxshot +100

[Helene Servillon @ JourneyOne 🌱 @HServillon]

@iiiitsandrea @thesnaxshot Have you heard of @sarstewart’s company Sugarless? One of my gfs called it “natural ozempic”

https://t.co/VuePK784l0

[Helene Servillon @ JourneyOne 🌱 @HServillon]

@investing_law I live out here. If you need any recs, let me know 🙌🏼 I leave town on weds morning for mtgs in LA but have time to sync tomorrow late afternoon in downtown where my office is

[Helene Servillon @ JourneyOne 🌱 @HServillon]

@Michael_Asarch I appreciate your unwavering determination. People often overestimate what they can do in a year and underestimate what they can accomplish in a decade.

[Helene Servillon @ JourneyOne 🌱 @HServillon]

@michaelsaloio @withhuddle 👏🏼👏🏼👏🏼

[Helene Servillon @ JourneyOne 🌱 @HServillon]

@lucy_guo The robot servers at restaurants are ☑️

[Helene Servillon @ JourneyOne 🌱 @HServillon]

If you want to get high on your own supply 👇

https://t.co/EhxWYbA3g9

[Helene Servillon @ JourneyOne 🌱 @HServillon]

I did my first hr long transformational breathwork class and I was floored... What a profound experience. This is a MUST do for you curious cats out there.

"The breath is the cord that ties the soul to the body." — Paramahansa Yogananda

[Helene Servillon @ JourneyOne 🌱 @HServillon]

@CindyBiSV I recommend WishUp (india 1800/mo) - where my current EA is from. They have a service team that supports addit. EA training. For PI, Catena, more pricey in the 1750-3K/mo range depending on service you get. Happy to make an intro to either and will drop you their decks

[Helene Servillon @ JourneyOne 🌱 @HServillon]

@CindyBiSV @LinkedIn You've got a game winning linkedin headline 👏👏👏

Props.

[Helene Servillon @ JourneyOne 🌱 @HServillon]

Just how founders make product pivots, fund managers can and should make pivots in their investment thesis.

It's important to follow the waves of the market(s).

[Helene Servillon @ JourneyOne 🌱 @HServillon]

How do you define healing? And, what lens are you speaking from?

[Helene Servillon @ JourneyOne 🌱 @HServillon]

@lolitataub Always reach out. Persistence and proactiveness is key

[Helene Servillon @ JourneyOne 🌱 @HServillon]

SSRIs are estimated to be effective in only 25% of patients (Morgan Stanley, 2022), and also generate unwanted side effects for many people, including sexual dysfunction, nausea, drowsiness, insomnia, and weight gain.

[Helene Servillon @ JourneyOne 🌱 @HServillon]

The last major leap forward in treating mental health was in the 1980s, when SSRIs (selective serotonin reuptake inhibitors) like Prozac and Zoloft were brought to market.

[Helene Servillon @ JourneyOne 🌱 @HServillon]

Today they are a for-profit biotech company that brings new psychedelic drugs to market to treat mental health conditions, completing phase 3 clinical trials with 71.2% of the people in the trials no longer meeting the diagnostic criteria for PTSD

[Helene Servillon @ JourneyOne 🌱 @HServillon]

@MAPS PBC was formed to serve as their for-profit drug development org, recognizing that moving to a for-profit model was the only way to secure the substantial capital necessary to bring new FDA-approved drugs to market.

[Helene Servillon @ JourneyOne 🌱 @HServillon]

MDMA was developed in 1912 by the German pharma giant @Merck as a blood-clotting agent. The drug all but languished until the 1970s, when it was rediscovered by Berkeley-born chemist Alexander Shulgin.